eIF3e/Int6 is a component of the multi-subunit eIF3 complex, which binds directly to the 40S ribosome to facilitate ribosome recruitment to mRNA and hence protein synthesis. Reduced expression of eIF3e/Int6 has been found in up to 37% of human breast cancers, and expression of a truncated mutant version of the mouse eIF3e/Int6 protein leads to malignant transformation of normal mammary cells. These findings suggest that eIF3e/Int6 is a tumor suppressor; however, a recent study has reported that a reduction of eIF3e/Int6 expression in breast cancer cells leads to reduced translation of oncogenes, suggesting that eIF3e/Int6 may in fact have an oncogenic role in breast cancer. To gain a better understanding of the role of eIF3e/Int6 in breast cancer, we have examined the effects of decreased eIF3e/Int6 expression in an immortalized breast epithelial cell line, MCF-10A. Surprisingly, we find that decreased expression of eIF3e/Int6 causes breast epithelial cells to undergo epithelial-to-mesenchymal transition (EMT). We show that EMT induced by a decrease in eIF3e/Int6 expression imparts invasive and migratory properties to breast epithelial cells, suggesting that regulation of EMT by eIF3e/Int6 may have an important role in breast cancer metastasis. Furthermore, we show that reduced eIF3e/Int6 expression in breast epithelial cells causes a specific increase in the expression of the key EMT regulators Snail1 and Zeb2, which occurs at both the transcriptional and post-transcriptional levels. Together, our data indicate a novel role of eIF3e/Int6 in the regulation of EMT in breast epithelial cells and support a tumor suppressor role of eIF3e/Int6.
INTRODUCTION
The eIF3e/INT6 protein has been implicated in the development and progression of breast cancer. [1] [2] [3] The eIF3e/INT6 gene (herein referred to as eIF3e) was originally identified in mice as an integration site for the mouse mammary tumor virus. 4 Integration of mouse mammary tumor virus at the eIF3e locus leads to loss of normal eIF3e expression and instead causes the production of a truncated protein designated as Int6sh. 2 Ectopic expression of Int6sh causes malignant transformation of the normal mammary epithelial cells lines, HC11 (mouse) and MCF-10A (human), 2 indicating that a disruption of normal eIF3e activities lead to mammary tumor development. Additional studies confirmed a role for eIF3e in human breast cancer; examination of several human breast carcinomas showed a loss of heterozygosity for the human eIF3e gene in 21-28% of breast tumors and a reduced expression of eIF3e in 37% of breast cancers. 1 Together, these results suggest that loss of normal eIF3e activity is an important event in breast cancer development and progression.
eIF3e has been implicated in several cellular processes, including nonsense-mediated mRNA decay, 5 translation initiation 6, 7 and proteasomal degradation. 8, 9 As a component of the multi-subunit eIF3 translation initiation complex, eIF3e is involved in direct binding to both the initiation factor eIF4G and the 40S ribosomal subunit, thereby bridging an interaction between the ribosome and the eIF4F translation initiation complex; 7 however, previous studies have found that loss of eIF3e expression does not significantly affect global protein synthesis. 6, 10, 11 A recent report has shown that reduced expression of eIF3e causes changes in the translation of specific mRNAs, 11 suggesting that eIF3e may regulate the synthesis of specific proteins that contribute to cancer development and progression. Surprisingly, this study reported that eIF3e stimulates the translation of oncoproteins, in direct contrast to its previously established role as a tumor suppressor. eIF3e has also been recently shown to mediate the stability of oncoproteins through its roles in proteasomemediated degradation. 9 In this case, loss of eIF3e prevents the degradation of oncoproteins (such as steroid receptor coactivator 3), supporting a tumor suppressor role for eIF3e and suggesting another mechanism by which reduced eIF3e expression can lead to oncogenic transformation. Despite the advances made by these studies, the exact role of eIF3e in breast cancer development and progression, and its underlying mechanisms, remain unclear.
Epithelial-to-mesenchymal transition (EMT) is an important event in embryonic development; the conversion of epithelial cells to mesenchymal cells (as well as the reverse process) permits the formation of adult tissues and organs. 12 EMT also has a role in cancer metastasis, as the changes induced by EMT allow cancer cells to adopt migratory properties that lead to the dissemination of tumor cells throughout the body. 13 In addition, cancer cells that have undergone EMT have increased resistance to apoptosis, oncogene-induced senescence and exhibit increased resistance to chemotherapy. 14, 15 EMT is primarily regulated by a group of transcription factors (for example, the EMT regulators Snail1, Snail2/Slug, Twist, and Zeb1/2) that simultaneously induce the expression of genes required for mesenchymal properties and repress the expression of genes that are required for the epithelial phenotype. 16 The expression of EMT regulators is controlled at the transcriptional level by proteins such as NF-kB and HIF-1, 17,18 at the post-transcriptional level by the translation regulator YB-1 19 and microRNAs (miR-200 family), 20, 21 and at the post-translational level by proteasomal degradation. 22 The important role of EMT in cancer has become increasingly clear, yet we do not fully understand how this process is regulated.
We now show that decreased eIF3e expression in breast epithelial cells causes EMT by increasing the expression of the critical EMT regulators Snail1 and Zeb2. We find that while the abundance of both Snail1 and Zeb2 mRNA is increased, reduced eIF3e expression causes stabilization of only Zeb2 mRNA. Moreover, although decreased eIF3e expression reduces the level of global protein synthesis, both Snail1 and Zeb2 mRNAs are preferentially translated when eIF3e is reduced. These findings suggest that a reduction in eIF3e affects the expression of the EMT regulators Snail1 and Zeb2 at both the transcriptional and post-transcriptional levels. Importantly, EMT that is driven by reduced eIF3e expression imparts metastatic characteristics to breast epithelial cells, such as increased migratory potential and invasiveness. Our data suggest that decreased eIF3e expression in breast epithelial cells alters, at multiple levels, the expression of genes that drive cancer metastasis.
RESULTS
A decrease in eIF3e expression causes EMT in breast epithelial cells Two recent reports have examined the role of eIF3e in breast cancer, with each drawing conflicting conclusions. 9, 11 In one scenario, eIF3e was reported to behave like an oncoprotein, as its reduced expression in breast cancer cell lines causes decreases in the translation of oncogenes, reduced cell proliferation and decreased metastatic potential; 11 however, another study found that eIF3e has a tumor suppressor role in breast cancer, as reduced eIF3e expression causes abnormalities in breast acinar structure and enhances the ability of breast epithelial cells to form colonies in soft agar. 9 We chose to further examine the role of eIF3e in breast epithelial cells by creating stable clones of the immortalized breast epithelial cell line MCF-10A 23 in which eIF3e expression is reduced by short hairpin RNAs (shRNAs) that specifically target eIF3e mRNA.
Upon selection of stable cell clones that harbor shRNA specific for eIF3e (Figure 1a) , we found that these MCF-10A breast epithelial cells display an altered morphology (Figure 1b) . Stable clones that harbor a non-silencing control shRNA exhibit the cuboidal morphology of epithelial cells, whereas stable clones that have significantly reduced eIF3e expression exhibit a spindle-like morphology that is similar to fibroblastic cells (Figure 1b) . Interestingly, this alteration in cell morphology is reminiscent of the changes that occur during EMT. 16 Therefore, to determine if MCF-10A cells that have reduced eIF3e expression undergo EMT, we examined stable cell clones harboring eIF3e shRNA for the expression of epithelial-and mesenchymal-specific proteins. Both confocal immunofluorescence microscopy and western blot analysis showed that MCF-10A cells with decreased eIF3e expression also lose expression of the epithelial markers E-cadherin and ZO-1 (Figures 2a and b) . Furthermore, a reduction in eIF3e levels causes increased expression of the mesenchymal markers N-cadherin and vimentin (Figures 2a and b) . These results suggest that reduced eIF3e expression causes breast epithelial cells to undergo EMT. eIF3e in breast cancer. Previous reports have shown that loss of eIF3e expression causes a reduction in proliferation, 11, 24 which has been interpreted as showing a key role for eIF3e in driving cell proliferation and hence cancer progression, 11 and therefore suggests that eIF3e is an oncoprotein. However, reduced proliferation is known to accompany EMT and allows cancer cells to enter a 'dormant' state during metastasis. 25 Moreover, cells that have undergone EMT gain the capacity to migrate, and therefore EMT is thought to have an important role in the metastasis of tumor cells. 13 We therefore chose to examine the effect of reduced eIF3e expression on the proliferation and the migratory properties of breast epithelial cells.
We examined the proliferation of MCF-10A cells that harbor a non-silencing control shRNA and MCF-10A cells that harbor eIF3e-specific shRNAs (stable clones 83-4, 205-2, 205-3); we found that the proliferation of MCF-10A cells with decreased eIF3e expression is significantly reduced compared with MCF-10A cells that harbor a non-silencing control shRNA (Figure 3a ). These observations suggest that a decrease in eIF3e expression significantly reduces the proliferation of breast epithelial cells, which is consistent with previously published results. 11 Moreover, the reduced proliferation caused by a decrease in eIF3e expression is typical of cells that have undergone EMT. 25 To examine the migratory capabilities of MCF-10A cells that have reduced eIF3e expression, we employed a cell migration assay that utilizes transwell inserts. We found that few MCF-10A cells that harbor the non-silencing control shRNA migrate toward a serum stimulus (10% serum), whereas significant numbers of MCF-10A cells with decreased eIF3e expression migrate toward the serum stimulus ( Figure 3b) . Surprisingly, MCF-10A cells with reduced eIF3e expression migrate in significant numbers even in the absence of any stimulus (Figure 3b ), suggesting that these cells have adopted a constitutive migratory phenotype. These data indicate that reduced eIF3e expression in breast epithelial cells causes enhanced migration, a hallmark of cells that have undergone EMT.
Reduced expression of eIF3e prevents the formation of acini by breast epithelial cells grown in three-dimensional culture Breast epithelial cells, such as the MCF-10A cell line, can form three-dimensional structures that resemble the normal architecture of mammary glands, known as acini. 26 These structures have a spheroid morphology that consists of a single layer of cells surrounding a hollow lumen, and are formed by breast epithelial cells that are grown on reconstituted laminin-rich basement membranes (Matrigel). It has been previously observed that reduced expression of eIF3e in a Ras-transformed MCF-10A cell line (MCF-10AT) causes the formation of abnormally shaped acini. 9 Moreover, MCF-10AT cells that are induced to undergo EMT by overexpression of the YB-1 protein completely fail to form acini, and instead develop into cord-like networks of cells. 19 As we have found that reduced eIF3e expression in MCF-10A cells causes EMT and an enhancement in migration, we examined the ability of MCF-10A cells with reduced eIF3e expression to form acini.
MCF-10A cells that harbor a non-silencing control shRNA and MCF-10A cells that harbor eIF3e-specific shRNAs (stable clones 83-4, 205-2, 205-3) were seeded onto Matrigel and allowed to grow for 10 days. After 4 days of growth, the formation of acinar structures was evident for MCF-10A cells that harbor the nonsilencing control shRNA (Figure 3c ), and these structures continued to develop through day 10. In contrast, MCF-10A cells that have reduced eIF3e expression failed to form acini even after 10 days, and instead formed cord-like networks of cells (Figure 3c ). These data indicate that breast epithelial cells that have reduced eIF3e expression adopt an invasive phenotype, which could contribute to the ability of metastatic breast cancer cells to invade adjacent tissue and initiate a metastatic cascade.
Reduced expression of eIF3e causes increased expression of the EMT regulators Snail1 and Zeb2 EMT is controlled by several key transcription factors, such as Snail1, Snail2/Slug, Twist, and Zeb2, which regulate the expression of both mesenchymal-and epithelial-specific genes. 16 To determine whether reduced eIF3e expression in breast epithelial cells induces EMT by changing the expression levels of key EMT regulators, we first performed western blot analysis for Snail1, Snail2/Slug, Twist and Zeb2 on protein extracts from MCF-10A cells that harbor eIF3e-specific shRNA and MCF-10A cells that harbor a control shRNA. We found that MCF-10A cells that have decreased eIF3e levels show an increase in the expression of both the Snail1 and Zeb2 proteins, whereas the expression levels of the Snail2/Slug and Twist proteins remain unchanged (Figure 4a ). This result suggests that a decrease in eIF3e expression may lead to EMT by primarily changing the expression of the EMT regulators Snail1 and Zeb2. To determine whether eIF3e causes a change in the mRNA levels of the key EMT regulators, we examined the total mRNA abundance for Snail1, Snail2/Slug, Twist and Zeb2 in both control MCF-10A cells and MCF-10A cells with reduced eIF3e expression by quantitative reverse-transcriptase PCR (qRT-PCR). We found a significant increase in the abundance of both Snail1 and Zeb2 mRNA in MCF-10A cells with reduced eIF3e expression, but no changes in the abundance of Snail2/Slug and Twist mRNAs (Figure 4b ). These data suggest that a reduction in eIF3e expression causes changes in the abundance of mRNAs that encode key EMT regulators.
To determine whether decreased eIF3e expression increases the abundance of Snail1 and Zeb2 mRNA at the transcriptional or post-transcriptional level, we performed mRNA stability analyses for these mRNAs in MCF-10A cells that harbor eIF3e shRNA or a non-silencing shRNA control. Our data indicate that a decrease in eIF3e expression causes increased stability of Zeb2 mRNA, but has no effect on the stability of Snail1 mRNA (Figure 4c ). This result suggests that reduced eIF3e expression leads to increased transcription of Snail1 mRNA and increased stability of Zeb2 mRNA.
Snail1 and Zeb2 mRNA are preferentially translated when eIF3e expression is reduced Evdokimova et al. 19 have recently shown that increased expression of YB-1, a protein that regulates translation initiation, can induce EMT in breast epithelial cells. Moreover, increased YB-1 expression mediates EMT by causing a specific increase in the translation of Snail1, a key regulator of EMT. 27 As eIF3e is a component of the multi-subunit translation initiation complex eIF3, 28 we decided to examine whether reduced eIF3e expression affects the expression of Snail1 and Zeb2 by altering their translation in breast epithelial cells.
To examine changes in the translation of Snail1 and Zeb2 mRNAs, cytoplasmic extracts from MCF-10A cells that harbor a non-silencing control shRNA and MCF-10A cells that harbor eIF3e-specific shRNA (clone 205-2) were subjected to polysome profiling. Polysomes are complexes of translating ribosomes engaged with mRNA, and separation of polysomes by density-gradient ultracentrifugation followed by detection of RNA position in the gradient by the absorbance of ultraviolet light (254 nm) results in a distinct profile that provides a snapshot of the global efficiency of translation. 29 Well-translated mRNAs have many ribosomes associated with them and therefore cosediment with highmolecular weight polysome complexes, whereas poorly translated mRNAs have few ribosomes associated with them and therefore cosediment with low-molecular weight polysome complexes. Interestingly, we found that the abundance of mRNAs engaged with high-molecular weight polysomes is significantly reduced in cells that harbor eIF3e-specific shRNA (Figure 5a ), suggesting that eIF3e may be required for global translation in breast epithelial cells. This is in agreement with a previous report that showed reduced global translation in cells that express lower levels of eIF3e. 9 We subsequently harvested mRNA from each gradient fraction, which we then analyzed by qRT-PCR using oligonucleotide primers that specifically amplify sequences from the Snail1 and Zeb2 mRNAs, as well as glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA, which served as a control for the effect of eIF3e reduction on global translation. We found that GAPDH mRNA shifted from the heavy polysome fractions to nonpolysomal fractions upon a reduction of eIF3e expression (Figure 5b) , which is consistent with the conclusion that global translation initiation is decreased in cells that have reduced eIF3e Cytoplasmic extracts containing polysomes were loaded onto a 10-50% sucrose gradient and polysomes were separated by ultracentrifugation in a Beckman SW41 rotor at 36 000 r.p.m. for 1 h 50 min. The sucrose gradients were fractionated using an ISCO Foxy Jr fractionator and absorbance at 254 nm was monitored using a ultraviolet spectrophotometer. (b) Snail1 and Zeb2 mRNA continue to be translated in MCF-10A cells with reduced expression of eIF3e despite a decrease in global translation. Polysomal and nonpolysomal mRNA for control and eIF3e-silenced MCF-10A cells was harvested from each gradient fraction, which was collected as described in a, and subsequently used as templates for quantitative RT-PCR analysis of Snail1, Zeb2 and GAPDH. The abundance of mRNA in each fraction is plotted as a percentage of total mRNA. Graphs are a summary of three independent experiments. expression. In contrast, we found that Snail1 mRNA was retained in the polysomal fractions upon reduction of eIF3e expression and that Zeb2 mRNA was in fact shifted into the heavy polysome fractions when eIF3e expression was reduced (Figure 5b ). These data indicate that reduced eIF3e expression causes both Snail1 and Zeb2 mRNA to continue to be translated despite a decrease in global protein synthesis.
DISCUSSION
Previous studies have reported that eIF3e may act as either a tumor suppressor [1] [2] [3] 9 or an oncogene 11 in breast cells. We now show that decreased expression of eIF3e in breast epithelial cells leads to EMT, which in turn imparts invasive and migratory properties to breast epithelial cells. Importantly, we have been able to replicate these basic findings in two unrelated breast epithelial cells lines, MCF-10A and MCF-12A 30 ( Supplementary  Figure 1) , suggesting that EMT generally occurs in breast epithelial cells that have reduced eIF3e expression. We further show that a reduction in eIF3e levels leads to an increase in the expression of the key EMT regulators Snail1 and Zeb2, which is mediated by changes in their transcription, mRNA stability and translation. Together, our data support the idea that eIF3e is a tumor suppressor that performs its function by affecting the expression of proteins involved in invasion and migration (for example, EMT regulators) at multiple levels of gene expression control.
EMT has emerged as an important event in the initiation of cancer metastasis, 31 as it gives rise to phenotypic changes that facilitate the migration of cells from the originating site of the tumor to distal sites in the body. The finding that reduced eIF3e expression induces EMT in breast epithelial cells suggests that a reduction in eIF3e abundance or activity may be an important event in the initiation of breast cancer metastasis. Moreover, our data provide additional evidence that eIF3e indeed has a tumorsuppressive role, as its activities appear to prevent cells from adopting metastatic characteristics. Our data provide new insight into how EMT may be regulated and suggest that the expression level (and/or activity) of the eIF3e translation initiation factor is an important determinant for whether epithelial cells undergo the mesenchymal transition. Our results indicate that one way in which eIF3e fulfills its regulatory role in EMT is by controlling the expression of key transcription factors that mediate this process (see below).
We have found that a decrease in eIF3e expression leads to an increase in the abundance of mRNAs that encode the EMT regulators Snail1 and Zeb2. Although it is not immediately clear how a decrease in eIF3e expression may affect the transcription of Snail1 mRNA, the eIF3e protein has been implicated in multiple processes that regulate protein expression, such as nonsense-mediated decay, 5 proteasome function 9 and translation initiation.
7,11 Therefore, it is entirely possible that reduced eIF3e expression may affect the expression of proteins that participate directly in Snail1 transcription or that are part of signaling pathways that are upstream of Snail1 expression. Similarly, eIF3e may control the stability of Zeb2 mRNA by directly participating in the processes that mediate Zeb2 mRNA degradation (such as nonsense-mediated decay), or eIF3e may control the expression of key proteins in these mRNA degradation pathways. We should also note that we cannot rule out the possibility that some of the gene expression changes we have observed in cells that have reduced eIF3e expression levels may be the result of events that occur downstream of the direct effects of eIF3e.
Our data suggest that a decrease in eIF3e expression may lead to EMT by permitting the preferential translation of Snail1 and Zeb2 mRNAs. Snail1 mRNA translation has been previously shown to be increased upon induction of EMT, as overexpression of the YB-1 translation regulator, which induces EMT in breast epithelial cells, causes a specific increase in Snail1 translation. 19 The Snail1 5 0 untranslated region (UTR) is very GC rich and capable of forming stable stem-loop structures, which could be refractory to the global, cap-dependent translation initiation mechanism, 32 indicating that Snail1 mRNA may utilize an alternative mechanism for its translation. It has been suggested that the Snail1 5 0 UTR mediates translation of Snail1 via an internal ribosome entry site (IRES), as translation of Snail1 5 0 UTRcontaining reporter constructs persists during inhibition of global, cap-dependent translation initiation. 19 We have found that a reduction in eIF3e levels causes a decrease in global translation, yet translation of Snail1 mRNA persists under these conditions. These observations suggest that decreased eIF3e expression creates an environment that favors the Snail1 translation initiation mechanism. It is also important to note that the Zeb2 5 0 UTR contains an IRES 33 and therefore may be subjected to the same type of alternative translation initiation as Snail1 under the conditions of reduced global, cap-dependent translation. These observations raise the possibility that decreased expression of eIF3e in breast epithelial cells leads to preferential translation of proteins that utilize an IRES-dependent mechanism for their synthesis, such as Snail1 and Zeb2, which in turn mediate the EMT. In support of this hypothesis, a recent report has shown that expression of a truncated mutant version of eIF3e, which lacks normal eIF3e activity, in NIH3T3 cells causes a decrease in global, cap-dependent translation initiation and a concurrent increase in the translation of mRNAs that contain IRES, 34 suggesting that reduced eIF3e activity favors IRES-dependent translation initiation.
Our data highlight an important role for eIF3e in the regulation of EMT in breast epithelial cells. This discovery has implications for understanding the role of eIF3e in breast cancer development and progression. Our findings uncover a previously unappreciated role for reduced eIF3e expression in the development of metastatic properties by breast cancer cells, and reinforce the hypothesis that eIF3e is a tumor suppressor whose loss mediates cancer growth and progression. Furthermore, our studies lend support to a growing body of evidence that implicates regulated protein synthesis in the control of EMT. 19, [35] [36] [37] Future studies that examine the mechanisms that underlie eIF3e's effect on the translation of EMT regulators, as well as the identification of novel eIF3e targets, will help us to better understand how a decrease in eIF3e expression may drive breast cancer metastasis.
MATERIALS AND METHODS
Cell culture and shRNA transduction MCF-10A cells and MCF-12A cells were obtained from ATCC (Manassas, VA, USA) and maintained in DMEM/F12 media supplemented with 5% fetal bovine serum, 2 mM L-glutamine, 1 mM sodium pyruvate, 500 ng/ml hydrocortisone, 100 ng/ml Cholera toxin, 20 ng/ml epidermal growth factor and 1% penicillin/streptomycin. To reduce eIF3e expression, cells were transduced with the pSMP Retroviral shRNAmir system (Open Biosystems, Lafayette, CO, USA), which carried shRNA sequences that are specific to eIF3e (eIF3e shRNA 83: 5 0 -GUCUUUCCGCUUCUUGAAUUU-3 0 ; 24 eIF3e shRNA 205: 5 0 -AACCUUUAUUCUGAUGAUAUUC-3 0 ) or a non-silencing control sequence. Single-cell clones were selected and maintained in 1.5 mg/ml puromycin.
Western blot analyses
Cells were either lysed in radioimmuno precipitation assay (RIPA) buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 0.25% sodium deoxycholate, 0.1% SDS) with 1:100 dilution of Protease Inhibitor Cocktail Set III (EMD Chemicals, Gibbstown, NJ, USA) or lysed by boiling in SDS-PAGE sample buffer (63 mM Tris HCl, 10% glycerol, 2% SDS, pH 6.8). Protein was quantified using BCA Protein Assay Kit (Pierce, Rockford, IL, USA) and equal amounts were loaded onto SDS-PAGE. Proteins were transferred to 0.45-mm polyvinylidene difluoride and probed with antibodies that recognize eIF3e (Abcam, Cambridge MA, USA), b-actin (Santa Cruz Biotechnology, Santa Cruz CA, USA), E-cadherin (BD Biosciences, Franklin Lakes, NJ, USA), ZO-1 (Invitrogen, Camarillo CA, USA), N-cadherin (BD Biosciences), Snail1 (Abcam), Snail2/Slug (Santa Cruz Biotechnology), Twist (Santa Cruz Biotechnology) and Zeb2 (Santa Cruz Biotechnology). Blots were visualized using the ECL Plus chemilumenescent reagent (GE Healthcare, Piscataway, NJ, USA) and a VersaDoc Imaging System (Bio-Rad, Hercules, CA, USA).
Immunofluorescence microscopy Cells were grown to confluency in chamber slides, washed, fixed in 3.7% formaldehyde for 15 min, washed again and permeabilized for 5 min with 0.1% Triton X-100 in phosphate-buffered saline (PBS). PBS containing 2% BSA, 0.1% Triton X-100 was used to block slides for 30 min, which were then incubated with primary antibody at 4 1C overnight. Slides were washed with 0.1% Triton X-100 in PBS, incubated in secondary antibody for 2 h at room temperature, washed again and mounted. Cells were visualized at Â 60 magnification using an Olympus IX81 microscope and FW10-ASW software (Center Valley, PA, USA).
Proliferation assay
Briefly, equal numbers of cells were plated in triplicate a 96-well plate. Cell Titer Blue substrate (Promega, Madison, WI, USA) was added daily, incubated for 30 min at 37 1C in 5% CO 2 and fluorescence recorded at 560 Ex /590 Em . Days 1-5 fluorescence readings were normalized to day 0 and plotted accordingly.
Migration assay
Cells were starved overnight in 0.1% serum-containing media. 1 Â 10 4 cells in 0.1% serum were seeded in the upper chamber of 24-well-sized transwell inserts (8.0 mm pore size; VWR International, Mississauga, ON, Canada). Inserts were incubated 12 h at 37 1C in 5% CO 2 with 0.1% or 10% serum-containing media in the lower chambers. Transwell inserts were washed with PBS and non-migrated cells on the upper side of the membrane removed. Inserts were fixed in 4% paraformaldehyde and cells that had migrated were stained with 0.4% Crystal violet to visualize. Three separate fields of view were counted for each condition and each condition conducted in duplicate for each experiment.
Three-dimensional culture Briefly, 24-well plates were coated with 50% Matrigel (BD Biosciences) in MCF-10A growth media. Cells were seeded on top of solidified matrix in MCF-10A growth media with 2% Matrigel. Media with 2% Matrigel was replaced every 4 days. Cultures were monitored over time for the development of three-dimensional structures, which were photographed by phase-contrast microscopy on the days 4 and 10.
Polysome analysis and qRT-PCR Cytoplasmic extracts were harvested from MCF-10A cells that harbor a non-silencing control shRNA or the eIF3e shRNA (205, clone2) using standard procedures; 29 equal absorbance 260 nm units (A 260 ) of each cytoplasmic extract was loaded onto a 10-50% sucrose gradient and polysomes were separated by ultracentrifugation in a Beckman SW41 rotor (Mississauga, ON, Canada) at 36 000 r.p.m. for 1 h 50 min. The sucrose gradients were fractionated using an ISCO Foxy Jr fractionator (Lincoln, NE, USA) and absorbance at 254 nm was monitored using a ultraviolet spectrophotometer.
For qRT-PCR experiments, total mRNA was harvested from MCF-10A cells that harbor a non-silencing control shRNA or the eIF3e shRNA (205, clone 2) using an RNeasy RNA extraction kit (Qiagen, Germantown, MD, USA). Before the harvest of polysomal mRNA, 100 ng of chloramphenicol acyltransferase mRNA was added to each fraction to serve as an internal standard for mRNA isolation efficiency. Polysomal mRNA for control and eIF3e-silenced MCF-10A cells was harvested from each gradient fraction by precipitation with 1 volume of ice-cold isopropanol in the presence of 1/10 volume sodium acetate (pH B5.4) and 40 mg of Glycoblue (Life Technologies, Burlington, ON, Canada), which was followed by the RNAcleanup procedure from the RNeasy RNA extraction kit (Qiagen). cDNA was generated using the Quantitect Reverse Transcription Kit (Qiagen). qRT-PCR was performed to detect the EMT regulators Snail1 . The relative abundance of total mRNAs was determined using the 2 À DDCt method, 38 whereas the abundance of mRNA in each polysome fraction was determined using the standard curves method 39 and normalized to the abundance of chloramphenicol acyltransferase mRNA in each fraction (the internal standard).
mRNA stability analysis Analyses of mRNA stability were performed as previously described. 40 
